MARSHALL WACE, LLP

Holdings History for Trevi Therapeutics, Inc. - Common Stock, $0.001 par value per share (TRVI)

Symbol: TRVI on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.06%	-0%	$57,348,462	4,580,548	-261,203	-5.4%	$12.52	Q4 2025
30 Sep 2025	0.05%	+0.02%	$44,302,021	4,841,751	+2,363,835	+95%	$9.15	Q3 2025
30 Jun 2025	0.02%	-0%	$13,554,200	2,477,916	-76,305	-3%	$5.47	Q2 2025
31 Mar 2025	0.02%	+0.02%	$16,066,051	2,554,221	+2,511,300	+5800%	$6.29	Q1 2025
31 Dec 2024	0%	-0%	$176,835	42,921	-38,203	-47%	$4.12	Q4 2024
30 Sep 2024	0%	+0%	$270,954	81,124	+81,124	NEW	$3.34	Q3 2024
31 Dec 2022		-0%	$0	0	-128,324	-100%	$10.94	Q4 2022
30 Sep 2022	0%	+0%	$198,000	128,324	+128,324	NEW	$1.54	Q3 2022
30 Jun 2022		-0%	$0	0	-23,402	-100%	$10.94	Q2 2022
31 Mar 2022	0%	+0%	$52,000	23,402	+23,402	NEW	$2.22	Q1 2022

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.